LeonaBio Statistics
Want to see LONA full AI Analyst Report?
LeonaBio (LONA) Stock Statistics & Valuation Metrics
Total Valuation
LeonaBio has a market cap or net worth of $36.09M. The enterprise value is $52.90M.
- Market Cap
- $36.09M
- Enterprise Value
- $52.90M
Share Statistics
LeonaBio has 13,076,348 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 13,076,348
- Owned by Insiders
- 65.23%
- Owned by Institutions
- 9.92%
Financial Efficiency
LeonaBio’s return on equity (ROE) is -3.80 and return on invested capital (ROIC) is -226.69%.
- Return on Equity (ROE)
- -3.80
- Return on Assets (ROA)
- -1.15
- Return on Invested Capital (ROIC)
- -226.69%
- Return on Capital Employed (ROCE)
- -2.29
- Revenue Per Employee
- 0
- Profits Per Employee
- -5.56M
- Employee Count
- 19
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of LeonaBio is -0.09. LeonaBio’s PEG ratio is 0.00.
- PE Ratio
- -0.09
- PS Ratio
- 0.00
- PB Ratio
- 4.45
- Price to FCF
- -0.16
- Price to Operating Cash Flow
- -0.94
- PEG Ratio
- 0.00
Income Statement
In the last 12 months, LeonaBio had revenue of 0 and earned -105.61M in profits. Earnings per share was -24.70.
- Revenue
- 0
- Gross Profit
- -68.09M
- Operating Income
- -102.27M
- Pretax Income
- -105.61M
- Net Income
- -105.61M
- EBITDA
- -33.21M
- Earnings Per Share (EPS)
- -24.70
Cash Flow
In the last 12 months, operating cash flow was -61.93M and capital expenditures 0, giving a free cash flow of -61.93M billion.
- Operating Cash Flow
- -61.93M
- Free Cash Flow
- -61.93M
- Free Cash Flow per Share
- -3.21
Dividends & Yields
LeonaBio pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -672.81%
- Earnings Yield
- -228.97%
Stock Price Statistics
- Beta
- 1.22
- 52-Week Price Change
- -40.00%
- 50-Day Moving Average
- 5.34
- 200-Day Moving Average
- 7.50
- Relative Strength Index (RSI)
- 26.06
- Average Volume (3m)
- 193.22K
Important Dates
LeonaBio upcoming earnings date is Mar 25, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Nov 16, 2026
- Next Earnings Date
- Mar 25, 2027
- Ex-Dividend Date
- ―
Financial Position
LeonaBio as a current ratio of 1.88, with Debt / Equity ratio of 2.89%
- Current Ratio
- 1.88
- Quick Ratio
- 1.88
- Debt to Market Cap
- 0.01
- Net Debt to EBITDA
- 2.06
- Interest Coverage Ratio
- 0.00
Taxes
In the past 12 months, LeonaBio has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
LeonaBio EV to EBITDA ratio is 0.07, with an EV/FCF ratio of 0.06.
- EV to Sales
- 0.00
- EV to EBITDA
- 0.07
- EV to Free Cash Flow
- 0.06
- EV to Operating Cash Flow
- 0.06
Balance Sheet
LeonaBio has $51.07M in cash and marketable securities with $577.00K in debt, giving a net cash position of $50.49M billion.
- Cash & Marketable Securities
- $51.07M
- Total Debt
- $577.00K
- Net Cash
- $50.49M
- Net Cash Per Share
- $3.86
- Tangible Book Value Per Share
- $7.86
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Pretax Margin
- 0.00%
- Net Profit Margin
- 0.00%
- EBITDA Margin
- 0.00%
- EBIT Margin
- 0.00%
Analyst Forecast
The average price target for LeonaBio is $16.33, which is 11.43% higher than the current price. The consensus rating is Strong Buy
- Price Target
- $16.33
- Price Target Upside
- 491.79% Upside
- Analyst Consensus
- Strong Buy
- Analyst Count
- 3
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- -131.18%
Scores
- Smart Score
- 2
- AI Score
- 45

